Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI (Risk of Malignancy Index) and Tumor Markers Such as CA125 (Cancer Antigen 125) and HE4 (Human Epididymal Protein 4)

NCT02326064 is registered in ClinicalTrials.gov with Centre Hospitalier Departemental Vendee as lead sponsor.

NCT NCT02326064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02326064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI (Risk of Malignancy Index) and Tumor Markers Such as CA125 (Cancer Antigen 125) and HE4 (Human Epididymal Protein 4)
Lead sponsor
Centre Hospitalier Departemental Vendee
Phase
Observational
Overall status
Completed
Start date
May 31, 2015
Completion date
June 30, 2016
Enrollment
221 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer, ovarian tumor